The burden of disease in Spain: Results from the global burden of disease study 2010
Por:
Haro J.M., Tyrovolas S., Garin N., Diaz-Torne C., Carmona L., Sanchez-Riera L., Perez-Ruiz F., Murray C.J.L.
Publicada:
1 ene 2014
Resumen:
Background: We herein evaluate the Spanish population s trends in health burden by comparing results of two Global Burden of Diseases, Injuries, and Risk Factors Studies (the GBD studies) performed 20 years apart. Methods: Data is part of the GBD study for 1990 and 2010. We present results for mortality, years of life lost (YLLs), years lived with disability, and disability-adjusted life years (DALYs) for the Spanish population. Uncertainty intervals for all measures have been estimated. Results: Non-communicable diseases accounted for 3,703,400 (95% CI 3,648,270 3,766,720) (91.3%) of 4,057,400 total deaths, in the Spanish population. Cardiovascular and circulatory diseases were the main cause of mortality among non-communicable diseases (34.7% of total deaths), followed by neoplasms (27.1% of total deaths). Neoplasms, cardiovascular and circulatory diseases, and chronic respiratory diseases were the top three leading causes for YLLs. The most important causes of DALYs in 2010 were neoplasms, cardiovascular and circulatory diseases, musculoskeletal disorders, and mental and behavioral disorders. Conclusions: Mortality and disability in Spain have become even more linked to non-communicable diseases over the last years, following the worldwide trends. Cardiovascular and circulatory diseases, neoplasms, mental and behavioral disorders, and neurological disorders are the leading causes of mortality and disability. Specific focus is needed from health care providers and policy makers to develop health promotion and health education programs directed towards non-communicable disorders. © 2014 Haro et al.
Filiaciones:
Haro J.M.:
Universitat de Barcelona, Parc Sanitari Sant Joan de Du, Fundaci Sant Joan de Du. Dr Antoni Pujades, 42, Sant Boi de Llobregat, Barcelona, 08830, Spain
Centro de Investigacin Biomdica en Red de Salud Mental CIBERSAM, Instituto de Salud Carlos III, Dr. Esquerdo 46, Madrid, 28007, Spain
Tyrovolas S.:
Universitat de Barcelona, Parc Sanitari Sant Joan de Du, Fundaci Sant Joan de Du. Dr Antoni Pujades, 42, Sant Boi de Llobregat, Barcelona, 08830, Spain
Centro de Investigacin Biomdica en Red de Salud Mental CIBERSAM, Instituto de Salud Carlos III, Dr. Esquerdo 46, Madrid, 28007, Spain
Garin N.:
Universitat de Barcelona, Parc Sanitari Sant Joan de Du, Fundaci Sant Joan de Du. Dr Antoni Pujades, 42, Sant Boi de Llobregat, Barcelona, 08830, Spain
Centro de Investigacin Biomdica en Red de Salud Mental CIBERSAM, Instituto de Salud Carlos III, Dr. Esquerdo 46, Madrid, 28007, Spain
Diaz-Torne C.:
Universitat Autnoma de Barcelona, Unitat de Reumatologia. Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quint, 89, Barcelona, 08026, Spain
Carmona L.:
Instituto de Salud Musculoesqueltica (InMusc), Calle Hilarin, Eslava 2, Madrid, 28015, Spain
Sanchez-Riera L.:
Royal North Shore Hospital, University of Sydney, Institute of Bone and Joint Research, Pacific Hwy, St Leonards, NSW 2065, Australia
Hospital Universitari de Bellvitge, Institut d'Investigaci Biomdica de Bellvitge, Freixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
Perez-Ruiz F.:
Rheumatology Division, Cruces University Hospital, BioCruces Health Investigation Institute, Crystal-induced arthritis investigation team, Plaza de Cruces 12, Baracaldo, Vizcaya, 48903, Spain
Murray C.J.L.:
University of Washington, Institute for Health Metrics and Evaluation, 2301 Fifth Avenue,mSuite 600, Seattle, WA 98121, United States
All Open Access, Gold
|